Dashboard
Manage Tickers

BTMDbiote Corp.

Nasdaq biote.com


$ 5.76 $ -0.29 (-4.79 %)    

Tuesday, 07-May-2024 15:59:56 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 440.32 $ 0.07 (0.02 %)
DIA $ 388.70 $ 0.29 (0.07 %)
SPY $ 517.26 $ 0.57 (0.11 %)
TLT $ 90.79 $ 0.55 (0.61 %)
GLD $ 214.23 $ -0.99 (-0.46 %)
$ 5.77
$ 6.12
$ 5.76 x 200
$ 0.00 x 0
$ 5.74 - $ 6.26
$ 3.65 - $ 8.22
108,300
na
148.34M
$ 0.14
$ 44.74
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-15-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-11-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-29-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-21-2022 03-31-2022 10-Q
9 04-07-2022 12-31-2021 10-K
10 11-24-2021 09-30-2021 10-Q
11 08-17-2021 06-30-2021 10-Q
12 05-20-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biote-reiterates-guidance
Biote Reiterates Guidance
05/07/2024 22:15:39

2024 Financial Outlook"Based on our solid first quarter financial performance and our expectations for stronger revenue gro...

biote-q1-2024-gaap-eps-006-misses-003-estimate-sales-46804m-beat-45711m-estimate
Biote Q1 2024 GAAP EPS $(0.06) Misses $0.0...
05/07/2024 21:48:54

Biote (NASDAQ:BTMD) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.03 by 300 ...

biote-announces-definitive-settlement-with-founder-company-to-repurchase-all-of-founders-184m-shares-at-417-per-share
Biote Announces Definitive Settlement With...
04/29/2024 20:20:44

Company to repurchase all of Founder's 18.4 million shares at $4.17 per sharebiote Corp. (NASDAQ:BTMD) ("Biote" or ...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/29/2024 20:30:47

roth-mkm-reiterates-buy-on-biote-raises-price-target-to-9
Roth MKM Reiterates Buy on Biote, Raises P...
03/13/2024 15:12:05

Roth MKM analyst George Kelly reiterates Biote (NASDAQ:BTMD) with a Buy and raises the price target from $8 to $9.

biote-reaffirms-2024-financial-guidance-with-acceleration-in-h2-growth-sees-revenue-of-200m-204m-est-203167m-adjusted-ebitda-of-60m-63m
Biote Reaffirms 2024 Financial Guidance, W...
03/12/2024 20:52:53

Previously, Biote projected fiscal 2024 revenue of greater than $200 million and Adjusted EBITDA of greater than $60 million. F...

biote-q4-earnings-insights
Biote: Q4 Earnings Insights
03/12/2024 20:15:20

biote-q4-2023-gaap-eps-018-beats-008-estimate-sales-45703m-miss-45740m-estimate
Biote Q4 2023 GAAP EPS $0.18 Beats $0.08 E...
03/12/2024 20:13:20

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.18 per share which beat the analyst consensus estimate of $0.08 by 125 pe...

earnings-scheduled-for-march-12-2024
Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

preview-biotes-earnings
Preview: Biote's Earnings
03/11/2024 18:01:10

biote-announces-agreement-to-resolve-litigation-and-repurchase-all-of-founders-shares-company-to-repurchase-184m-class-a-shares-and-paired-interests-at-417-per-share
Biote Announces Agreement To Resolve Litig...
02/20/2024 21:14:00

Company to repurchase approximately 18.4 million Class A shares and Paired Interests at $4.17 per sharebiote Corp. (NASDAQ:BTMD...

jefferies-initiates-coverage-on-biote-with-buy-rating-announces-price-target-of-655
Jefferies Initiates Coverage On Biote with...
02/01/2024 13:02:02

Jefferies analyst Kaumil Gajrawala initiates coverage on Biote (NASDAQ:BTMD) with a Buy rating and announces Price Target of...

biote-announces-20m-share-repurchase-authorization
Biote Announces $20M Share Repurchase Auth...
01/25/2024 21:35:14

biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care th...

truist-securities-maintains-buy-on-biote-lowers-price-target-to-9
Truist Securities Maintains Buy on Biote, ...
01/18/2024 19:13:05

Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $10 to $9.

roth-mkm-maintains-buy-on-biote-lowers-price-target-to-7
Roth MKM Maintains Buy on Biote, Lowers Pr...
01/18/2024 14:03:48

Roth MKM analyst George Kelly maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $8 to $7.

biote-announces-definitive-agreement-to-acquire-fh-investments-inc-dba-asteria-health-a-privately-held-503b-manufacturer-of-compounded-bioidentical-hormones-for-85m
Biote Announces Definitive Agreement To Ac...
01/17/2024 21:09:58

Strategic and accretive transaction enables vertical integration of hormone product manufacturingbiote Corp. (NASDAQ:BTMD) (...

biote-sees-prelim-2023-revenue-of-185m-187m-vs-prior-forecast-of-lower-end-of-190m-200m-range
Biote Sees Prelim. 2023 Revenue Of $185M-$...
01/17/2024 21:08:26

biote-names-robert-peterson-as-chief-financial-officer-effective-january-8-2024
Biote Names Robert Peterson As Chief Finan...
01/11/2024 21:12:15

biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care th...

biote--sees-fy23-revenue-190m-200m-vs-19105m-est
Biote Sees FY23 Revenue $190M-$200M Vs $1...
11/08/2023 01:02:25

2023 Financial Outlook"Biote remains committed to driving profitable growth through the consistent execution of our strateg...

biote-q3-eps-024-beats-007-estimate-sales-4556m-miss-4790m-estimate
Biote Q3 EPS $0.24 Beats $0.07 Estimate, S...
11/07/2023 22:55:01

Biote (NASDAQ:BTMD) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $0.07 by 242.86...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION